Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03935958 · ClinicalTrials.gov registry record · NA
Curcumin in Kidney Transplant Recipients
A NA study of Disorder Related to Renal Transplantation, sponsored by University of Illinois at Chicago.
- Active
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03935958 is a NA study of Disorder Related to Renal Transplantation that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03935958, a NA study of Disorder Related to Renal Transplantation, is active but no longer recruiting, sponsored by University of Illinois at Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be evaluated as well as whether curcumin improves cognitive function in these patients.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Curcumin
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03935958
The ClinicalTrials.gov registry entry for NCT03935958 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disorder Related to Renal Transplantation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03935958 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03935958 about?
NCT03935958 is a clinical study titled "Curcumin in Kidney Transplant Recipients". The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment who have few treatment options. The possible mechanisms by which curcumin improves vascular function will be...
What is the current status of trial NCT03935958?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2019-11-01. Estimated completion is 2025-12.
What conditions does trial NCT03935958 study?
This clinical trial studies the following conditions: Disorder Related to Renal Transplantation.
What interventions are being tested in trial NCT03935958?
The interventions under investigation include: Placebo (OTHER), Curcumin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03935958?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03935958 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disorder Related to Renal Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.